BEIJING, March 26, 2026 /PRNewswire/ -- The 2026 Global South Financiers Forum opened in Beijing on Wednesday under the theme "Illuminating Global South."
Addressing the main forum, President of Xinhua News Agency Fu Hua said Xinhua is committed to amplifying the voice of the Global South and documenting its dynamic development.
He added that the agency will leverage its all-media network and global presence to promote deeper financial cooperation among Global South countries and contribute solutions to building a new global financial governance order.
Sun Shuo, vice mayor of Beijing, said the financial sector is a pillar of the city's economy. He noted that Beijing will remain committed to high-standard opening up and expand financial cooperation with Global South countries, with efforts focused on improving the business environment, strengthening sci-tech and financial integration, advancing green finance cooperation, and promoting higher-standard financial opening up.
Lu Lei, deputy governor of the People's Bank of China, said the central bank encourages financial institutions to carry out green and low-carbon investment in countries and regions participating in the Belt and Road Initiative.
He added that the central bank stands ready to work with all parties to advance high-quality development of green finance and guide capital toward green and low-carbon sectors.
Li Hongyan, deputy head of the State Administration of Foreign Exchange, said the restructuring of the global green industry presents win-win opportunities for China and other Global South countries.
Through high-standard financial opening up, China will deepen cooperation with other Global South countries in green industries, share opportunities and contribute to global sustainable development, Li said.
Erwin Ramirez, Nicaragua's minister of development, industry and trade, and Shahin Mahmudzada, executive director of the Central Bank of Azerbaijan, also addressed the forum. The two-day event is hosted by Xinhua.
Original link: https://en.imsilkroad.com/p/349905.html
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Xinhua Silk Road: 2026 Global South Financiers Forum held in Beijing
|
TOKYO, March 26, 2026 /PRNewswire/ -- NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality.
According to the World Health Organization (WHO), the global rise in lifestyle-related diseases and dementia underscores the urgency for advanced predictive diagnostics (*2). Concurrently, the Organisation for Economic Co-operation and Development (OECD) iLibrary data has identified cancer and cardiovascular diseases as leading causes of mortality worldwide (*3), amplifying the urgency for proactive health management solutions.
Royal Healthcare is based in Singapore's medical hub, Novena, providing personalized, high-quality health screening services alongside customized medical experiences that prioritize efficiency and convenience for both local and international patients.
The addition of the FonesVisuas Test represents a significant advancement by analyzing proteins that reflect dynamic physiological changes. From just a small blood sample, the test can predict risks of developing conditions such as dementia, heart attack, lung cancer, chronic kidney disease, and prostate cancer over the next several years.
Royal Healthcare combines its services with conventional health checkups to guide individuals who are not yet ill but also not in optimal health toward lifestyle improvements. This approach aims to prevent future illness and enhance people's quality of life.
Looking ahead, NEC plans to expand provision of the FonesVisuas Test internationally, particularly in the APAC region, underscoring its commitment to advancing global healthcare standards.
Notes
(*1) https://royal-healthcare.com/
(*2) https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases; https://www.who.int/news-room/fact-sheets/detail/dementia
(*3) https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2023_7a7afb35-en
About NEC
The NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group's approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.
For more information, please visit https://www.nec.com, and follow us on Instagram, Facebook, YouTube, and LinkedIn.
TOKYO, March 26, 2026 /PRNewswire/ -- NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality.
According to the World Health Organization (WHO), the global rise in lifestyle-related diseases and dementia underscores the urgency for advanced predictive diagnostics (*2). Concurrently, the Organisation for Economic Co-operation and Development (OECD) iLibrary data has identified cancer and cardiovascular diseases as leading causes of mortality worldwide (*3), amplifying the urgency for proactive health management solutions.
Royal Healthcare is based in Singapore's medical hub, Novena, providing personalized, high-quality health screening services alongside customized medical experiences that prioritize efficiency and convenience for both local and international patients.
The addition of the FonesVisuas Test represents a significant advancement by analyzing proteins that reflect dynamic physiological changes. From just a small blood sample, the test can predict risks of developing conditions such as dementia, heart attack, lung cancer, chronic kidney disease, and prostate cancer over the next several years.
Royal Healthcare combines its services with conventional health checkups to guide individuals who are not yet ill but also not in optimal health toward lifestyle improvements. This approach aims to prevent future illness and enhance people's quality of life.
Looking ahead, NEC plans to expand provision of the FonesVisuas Test internationally, particularly in the APAC region, underscoring its commitment to advancing global healthcare standards.
Notes
(*1) https://royal-healthcare.com/
(*2) https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases; https://www.who.int/news-room/fact-sheets/detail/dementia
(*3) https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2023_7a7afb35-en
About NEC
The NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group's approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.
For more information, please visit https://www.nec.com, and follow us on Instagram, Facebook, YouTube, and LinkedIn.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
